drugset / Trial / NCT03158168

Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts

NCT03158168

Phase 3 Unknown 70 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Warts are common and infectious viral diseases of the skin and are prevalent worldwide. Warts are caused by the human papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant .Although warts can appear at any age, they are more common in children and adolescents. The prognosis of warts cannot be predicted. In some patients they may spontaneously disappear, whereas others show persistence and progression with spreading to other body sites, leading to physical and emotional distress to the patients. \[ 1 \].

Timeline

Start
2018-03-01
Primary completion
2019-06
Completion
2019-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Candida albicans antigen Unknown 0.1 ml Other
Subject Candida albicans antigen Unknown 0.3 ml Other
Comparator Zinc Sulfate Unknown 0.1 ml Other
Comparator Zinc Sulfate Unknown 0.3 ml Other
Comparator Zinc Sulfate Unknown 2 % Other